STAT3 and non-small cell lung carcinoma: RNAi against CHRNA5 or STAT3 can lead to inhibition of cellular proliferation in NSCLC cell lines; and a mouse xenograft study shows that tumors derived from a CHRNA5-depleted small cell lung carcinoma cell line have lower size and weight in comparison to the controls [14].